CNB Bank’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

CNB Bank’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.02K	Hold	8	–	–	﹤0.01%	504
2025 Q4	$975	Hold	8	–	–	﹤0.01%	491
2025 Q3	$802	Hold	8	–	–	﹤0.01%	489
2025 Q2	$663	Hold	8	–	–	﹤0.01%	477
2025 Q1	$649	Hold	8	–	–	﹤0.01%	466
2024 Q4	$720	Sell	8 -8	-50%	-$775	﹤0.01%	472
2024 Q3	$1.58K	Hold	16	–	–	﹤0.01%	485
2024 Q2	$1.48K	Hold	16	–	–	﹤0.01%	484
2024 Q1	$1.52K	Sell	16 -299	-95%	-$27.7K	﹤0.01%	469
2023 Q4	$28.1K	Hold	315	–	–	0.02%	293
2023 Q3	$23K	Hold	315	–	–	0.01%	299
2023 Q2	$26.2K	Hold	315	–	–	0.02%	267
2023 Q1	$24K	Sell	315 -9	-3%	-$747	0.01%	281
2022 Q4	$26.9K	Sell	324 -14	-4%	-$1.13K	0.02%	261
2022 Q3	$27K	Hold	338	–	–	0.02%	258
2022 Q2	$25K	Hold	338	–	–	0.02%	259
2022 Q1	$30K	Sell	338 -17	-5%	-$1.57K	0.02%	256
2021 Q4	$40K	Sell	355 -1,163	-77%	-$140K	0.02%	238
2021 Q3	$191K	Buy	1,518 +293	+24%	+$37.7K	0.11%	150
2021 Q2	$166K	Buy	1,225 +139	+13%	+$18.3K	0.1%	160
2021 Q1	$147K	Buy	1,086 +385	+55%	+$57.6K	0.1%	165
2020 Q4	$99K	Buy	701 +126	+22%	+$16.1K	0.07%	172
2020 Q3	$64K	Buy	575 +296	+106%	+$33.2K	0.05%	197
2020 Q2	$31K	Buy	+279	New	+$27.5K	0.03%	240

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

CNB Bank's XBI Position: Q1 2026 in Review

CNB Bank held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q1 2026 at 8 shares worth $1.02K. The position accounts for ﹤0.01% of the portfolio, ranked #504.

CNB Bank first reported a position in XBI in Q2 2020 and has held it in 24 quarters since. The position peaked at $191K in Q3 2021. 813 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

CNB Bank held 8 shares of State Street SPDR S&P Biotech ETF worth $1.02K as of Q1 2026.
CNB Bank left its State Street SPDR S&P Biotech ETF share count unchanged in Q1 2026.
State Street SPDR S&P Biotech ETF made up ﹤0.01% of CNB Bank's portfolio in Q1 2026, its #504 holding.
CNB Bank first reported a position in State Street SPDR S&P Biotech ETF in Q2 2020 and has held it in 24 quarters since.
CNB Bank's State Street SPDR S&P Biotech ETF position peaked at $191K in Q3 2021.
813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on CNB Bank's 13F filing for Q1 2026, filed 6 May 2026.